QSAR and Molecular Docking Studies on a Series of Cinnamic Acid Analogues as Epidermal Growth Factor Receptor (EGFR) Inhibitors (original) (raw)

Abstract

Quantitative structure-activity relationship (QSAR) and docking studies have been performed on a large series of cinnamic acid analogues studied by various authors as Epidermal Growth Factor Receptor (EGFR) inhibitors. A multiple linear regression (MLR) analysis has shown that electronic properties of these compounds are the governing factors of their activity and docking study has shown that compounds can form hydrogen bonds with the receptor and have effective steric interactions involving dispersion forces. Using the MLR model, some new compounds were proposed that have higher potency than the existing ones.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (20)

  1. Leslie, B. J.; Holaday, C. R.; Nguyen, T.; Hergenrother, P. J. Phen- ylcinnamides as novel antimitotic agents. J. Med. Chem., 2010, 53, 3964-3972.
  2. Cutillo, F.; D'Abrosca, B.; DellaGreca. M.; DiMarino, C.; Golino, A.; Previtera. L.; Zarrelli, A. Cinnamic acid amides from Chenopo- dium album: effects on seeds germination and plant growth. Phyto. Chem., 2003, 64, 1381-1387.
  3. Zhang, M.; Lu. X.; Zhang, H.-J.; Li, N.; Xiao, Y.; Zhu, H.-L.; Ye, Y.-H. Synthesis, structure, and biological assay of cinnamic amides as potential EGFR kinase inhibitors. Med. Chem. Res., 2013, 22, 986-994.
  4. Qian, Y.; Zhang, H.-J.; Hao, Zhang.; Xu, C.; Zhao, J.; Zhu, H.-L. Synthesis, molecular modeling, and biological evaluation of cin- namic acid metronidazole ester derivatives as novel anticancer agents. Bioorg. Med. Chem., 2010, 18, 4991-4996.
  5. Li, D.-D.; Lv, P.-C.; Zhang, H.; Zhang, H.-J.; Hou, Y.-P.; Liu. K.; Ye, Y.-H.; Zhu, H.-L. The combination of 4-anilinoquinazoline and cinnamic acid: A novel mode of binding to the epidermal growth factor receptor tyrosine kinase. Bioorg. Med. Chem., 2011, 19, 5012-5022.
  6. Talete srl, Dragon (Software for Molecular Descriptor Calculation) Version 6.0 -2013 -http://www.talete.mi.it/.
  7. Gramatica, P.; Chirico, N.; Papa, E.; Cassani, S.; Kovarich, S. QSARINS: A new software for the development, analysis, and validation of QSAR MLR Models. J. Comput. Chem., 2013, 34, 2121-2132.
  8. Gramatica, P.; Cassani, S.; Chirico, N. QSARINS-Chem: Insubria datasets and new QSAR/QSPR models for environmental pollutants in QSARINS. J. Comput. Chem., 2014, 35, 1036-1044.
  9. Shi, L. M.; Fang, H.; Tong, W.; Wu, J.; Perkins, R.; Blair, R. M.; Branham, W. S.; Dial, S. L.; Moland, C. L.; Sheehan, D. M. QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci., 2001, 41, 186 195.
  10. Schüürmann, G.; Ebert, R.; Chen, J.; Wang, B.; Kühne, R. External validation and prediction employing the predictive squared correlation coefficients test set activity mean vs training set activity mean. J. Chem. Inf. Model., 2008, 48, 2140 2145.
  11. Consonni, V.; Ballabio, D.; Todeschini, R. Comments on the definition of the Q 2 parameter for QSAR validation. J. Chem. Inf. Model., 2009, 49,1669 1678.
  12. Consonni, V, Ballabio, D.; Todeschini R. Evaluation of model predictive ability by external validation techniques. J. Chemom., 2010, 24, 194 201.
  13. Ojha, P. K.; Mitra, I.; Das, R. N.; Roy, K. Further exploring r 2 m metrics for validation of QSPR models. Chemom. Intell. Lab. Syst., 2011, 107, 194 205.
  14. Ojha, P. K.; Roy, K. Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection. Chemom. Intell. Lab. Syst., 2011, 109, 146 161.
  15. Chirico, N.; Gramatica, P. Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient. J. Chem. Inf. Model., 2011, 51, 2320 2335.
  16. Lin, L. I. A concordance correlation coefficient to evaluate reproducibility. Biometrics, 1989, 45, 255 268.
  17. Deeb, O.; Clare, B. W. QSAR of aromatic substances: EGFR in- hibitory activity of quinazoline analogues. J. Enzyme Inhib. Med. Chem., 2008, 23,763-75
  18. Sun, M.; Chen, J.; Cai, J.; Cao, M.; Yin, S.; Min, Ji. Simultane- ously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2 inhibitors. Chem. Biol. Drug Des., 2010, 75, 494-505.
  19. Zhang, W.-M.; Xing, M.; Zhao, T.-T.; Ren, Y.-J.; Yang, X.-H.; Yang, Y.-S.; Lv, P.-C.; Zhu, H.-L. Synthesis, molecular modeling and biological evaluation of cinnamic acid derivatives with pyra- zole moieties as novel anticancer agents. R.S.C. Adv., 2014, 4, 37197-37207.
  20. Agarwal, N.; Bajpai, A.; Srivastava, V.; Gupta, S. P. A quantitative structure-activity relationship and molecular modeling study on a series of biaryl imidazole derivatives acting as H + /K + -ATPase in- hibitors. Struct. Biol., 2013, 2013, 11.